High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1688-1695

  Oyunsuren, Tsendsuren ^a   Kurbanov, Fuat ^b   Tanaka, Yasuhito ^b   Elkady, Abeer ^b   Sanduijav, Ruvjir ^c,d   Khajidsuren, Onkhoon ^c   Dagvadorj, Byambin ^e   Mizokami, Masashi ^b  

^a INSTITUTE OF CHEMISTRY AND CHEMICAL TECHNOLOGY   (Mongolia)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c National Cancer Center   (Mongolia)

^d Health Sciences University   (Mongolia)

^e Ministry of Health   (Mongolia)

Author keywords

Co infection; HBV; HCC; HCV; HDV; Mongolia

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TUMOR MARKER;

ADULT; ARTICLE; CHRONIC HEPATITIS; COMORBIDITY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MONGOLIA; NONHUMAN; PREVALENCE; PROTEIN BLOOD LEVEL; VIREMIA;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; MONGOLIA; PREVALENCE;

DELTAVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33750571117     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20755     Document Type: Article

References (33)

1. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37:2899-2903.
2. Bosch FX, Ribes J, Diaz M, Cleries R. 2004. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127:S5-S16.
3. Crespo J, Lozano JL, Carte B, de las Heras B, de la Cruz F, Pons-Romero F. 1997. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 16:445-451.
4. Donate F, Boffetta P, Puoti M. 1998. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347-354.
5. Dulamsuren S. 2004. Report of the Ministry of Health, Mongolia. Health Indicators. Vol. 58.
6. Fujioka S, Shimomura H, Ishii Y, Kondo J, Fujio K, Ikeda F, Miyake M, Kusachi S, Tsuji T. 1998. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 72:5-11.
7. Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. 2002. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 62 Suppl 1:57-63.
8. Govindarajan S. 1990. Inhibition of HBV replication during coinfection with HBV and HDV: Inhibition of the inhibition by coinfection with HIV. Hepatology 11:703-704.
9. Huang YH, Wu JC, Chau GY, Tsay SH, King KL, Sheng WY, Lui WY, Lee SD. 1998. Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol 33:512-516.
10. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J. 2001. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34:404-410.
11. Kato H, Mizokami M, Nakano T, Kondo Y, Dashnyam B, Oyunsuren T, Ueda R. 1999. High prevalence and phylogenetic analysis of TT-virus infection in Mongolia. Virus Res 60:171-179.
12. Koike K, Yasuda K, Yotsuyanagi H, Moriya K, Hino K, Kurokawa K, Iino S. 1995. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol 45:236-239.
13. Kondo Y, Mizokami M, Nakano T, Kato T, Ueda R, Mukaide M, Hikiji K, Ishida T, Dorjsuren D, Dashnyam B, Oyunsuren T. 1997. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. J Med Virol 52:143-148.
14. Liaw YF. 2001. Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger? J Gastroenterol Hepatol 16:597-598.
15. Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T. 2000. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 7:15-22.
16. Morante AL, de la Cruz F, de Lope CR, Echevarria S, Rodriguez GM, Pons-Romero F. 1989. Hepatitis B virus replication in hepatitis B and D coinfection. Liver 9:65-70.
17. Nakano T, Shapiro CN, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH. 2001. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 82:2183-2189.
18. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, et al. 1995. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 46:258-264.
19. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35:201-207.
20. Panigrahi AK, Nanda SK, Dixit RK, Acharya SK, Zuckerman AJ, Panda SK. 1994. Diagnosis of hepatitis C virus-associated chronic liver disease in India: Comparison of HCV antibody assay with a polymerase chain reaction for the 5′ noncoding region. J Med Virol 44:176-179.
21. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
22. Pontisso P, Gerotto M, Ruvoletto MG, Fattovich G, Chemello L, Tisminetzky S, Baralle F, Alberti A. 1996. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 48:157-160.
23. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, Squadrito G, Tono N. 2006. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43:100-107.
24. Semiletov Iu A, Pimenov VK, Ianina MV, Zubov SV, Shibnev VA. 2002. [Test for specific antibodies to virus hepatitis delta based on synthetic peptides]. Vopr Virusol 47:21-24.
25. Sheen IS, Liaw YF, Lin DY, Chu CM. 1994. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: A multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-361.
26. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H. 2004. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 11:392-398.
27. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, Acharya SK, Gish RG, Kramvis A, Kew MC, Yoshihara N, Shrestha SM, Khan M, Miyakawa Y, Mizokami M. 2004. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 40:747-755.
28. Tanaka Y, Kurbanov F, Mano S, Orito E, Vargas V, Esteban JI, Yuen MF, Lai CL, Kramvis A, Kew MC, Smuts HE, Netesov SV, Alter HJ, Mizokami M. 2006. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 130:703-714.
29. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. 2005a. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 77:491-499.
30. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. 2005b. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 150:2513-2528.
31. Usuda S, Okamoto H, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1998. An enzyme-linked immunosorbent assay with monoclonal antibodies for the determination of phosphorylated hepatitis B core protein (p21c) in serum. J Virol Methods 72:95-103.
32. Wang YM, Ng WC, Lo SK. 1999. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore. J Gastroenterol 34:481-485.
33. Yeh CT, Chiu CT, Tsai SL, Hong ST, Chu CM, Liaw YF. 1994. Absence of precore stop mutant in chronic dual (B and C) and triple (B, C, and D) hepatitis virus infection. J Infect Dis 170:1582-1585.